Additionally, the expression of FAISL was associated with the overall survival of head‐neck squamous cell carcinoma (p = 0.0088, HR = 1.53), kidney renal clear cell carcinoma (p = 1.9e‐12, HR = 2.82), liver hepatocellular carcinoma (p = 0.00092, HR = 1.84), lung adenocarcinoma (p = 0.015, HR = 1.43), pheochromocytoma and paraganglioma (p = 0.021, HR = 728 809 159.77), and bladder carcinoma (p = 0.029, HR = 1.39) (Figure S1J–O, Supporting Information) in the KM‐Plotter database. This evidence concerns the gene VPS9D1-AS1 and lung adenocarcinoma.